⌘K
Loading ticker…
As of 2026-08-24, Dare Bioscience, Inc. Common Stock (DARE) has a 3-month relative strength percentile of 4 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 29. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 13.0%, relative volume 0.43×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
DARE is in a stage 4 downtrend, week 4. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -49.9% / -57.1%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
DARE is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $452K notional.
Held by 2 ETFs · $841K across latest filings · largest weight 0.00% (VXF).
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $452K | — |
| VXFVanguard Extended Market ETF | 0.00% | $389K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DARE Jan avg: 14.04% median: 4.67% win: 75% σ: 26.49% n: 4 2022-04-12 → 2026-07-31 | DARE Feb avg: 12.26% median: -4.73% win: 25% σ: 43.38% n: 4 2022-04-12 → 2026-07-31 | DARE Mar avg: -3.88% median: -3.98% win: 25% σ: 9.42% n: 4 2022-04-12 → 2026-07-31 | DARE Apr avg: -6.73% median: -3.85% win: 40% σ: 23.53% n: 5 2022-04-12 → 2026-07-31 | DARE May avg: 8.33% median: 1.00% win: 80% σ: 14.56% n: 5 2022-04-12 → 2026-07-31 | DARE Jun avg: -10.56% median: -9.89% win: 0% σ: 8.29% n: 5 2022-04-12 → 2026-07-31 | DARE Jul avg: -16.91% median: -15.08% win: 20% σ: 15.77% n: 5 2022-04-12 → 2026-07-31 | DARE Aug avg: -5.59% median: -5.53% win: 25% σ: 8.63% n: 4 2022-04-12 → 2026-07-31 (current) | DARE Sep avg: -11.37% median: -8.45% win: 25% σ: 15.29% n: 4 2022-04-12 → 2026-07-31 | DARE Oct avg: 3.39% median: -4.83% win: 25% σ: 18.21% n: 4 2022-04-12 → 2026-07-31 | DARE Nov avg: -12.90% median: -13.23% win: 0% σ: 6.67% n: 4 2022-04-12 → 2026-07-31 | DARE Dec avg: -5.62% median: -7.83% win: 25% σ: 7.30% n: 4 2022-04-12 → 2026-07-31 |